McKinsey & Company

Business

Gallagher Posts Strong Q4 Growth, Eyes M&A Expansion Amid Stable Casualty Market

Arthur J. Gallagher & Co. reported robust revenue growth exceeding 30% for the fourth quarter of 2025, driven by a healthy mergers and acquisitions pipeline and resilient performance in key sectors. Leadership expressed confidence in navigating a softening property insurance market while maintaining stable casualty pricing and talent retention.

Jan 30, 2026

Business

P&G Bolsters Health Portfolio with Acquisition of Digestive Wellness Brand Wonderbelly

Consumer goods giant Procter & Gamble has agreed to acquire Wonderbelly, a fast-growing brand in the 'free-from' digestive health space, signaling a deeper push into the lucrative wellness category and a bid to attract younger, label-conscious consumers.

Jan 30, 2026

Business

Beyond the Benchmark: Three Fidelity ETFs Poised to Outpace the S&P 500

While the S&P 500 remains a core holding for many, actively managed and thematic ETFs offer a path to potentially superior returns. We analyze three Fidelity funds with distinct strategies—from U.S. tech dominance to international dividend income—that have historically beaten the market.

Feb 2, 2026

Business

Frost Bank Parent Company Cullen/Frost Announces Board Refresh, Adding McCombs Heir and Former EY Partner

Cullen/Frost Bankers Inc., the parent of Texas-based Frost Bank, has elected Marsha M. Shields, leader of the Red McCombs family enterprises, and former Ernst & Young managing partner Jeff Rummel to its board, as longtime director Dr. Chris Avery prepares to retire.

Feb 2, 2026

Business

S&P 500 Earnings Surge Past Forecasts, Fueling Market Optimism

Fourth-quarter earnings for S&P 500 companies are significantly outperforming expectations, led by robust growth in industrial and tech sectors, as investors await a busy week of corporate results and key economic data.

Feb 2, 2026

Business

A Strong Start: S&P 500's January Gain Hints at a Bullish 2026, Historical Trends Suggest

The S&P 500's 1.4% rise in January 2026 aligns with a decades-old market indicator, the 'January Barometer,' which historically signals strong full-year performance. Analysis of the past 40 years shows an 80% probability of gains through December following a positive January.

Feb 2, 2026

Business

Corcept Therapeutics Stock Plummets as FDA Reveals It Warned Company Against Drug Submission

Shares of Corcept Therapeutics plunged 16% after a corrected FDA letter disclosed the agency had repeatedly cautioned the company against filing its application for a Cushing's syndrome drug, which was later rejected over efficacy and safety concerns.

Jan 30, 2026

Business

Latham & Watkins Tops 2025 TMT M&A Legal Rankings, Kirkland & Ellis in Close Pursuit

A new industry report reveals Latham & Watkins advised on a record $370bn in tech, media, and telecom deals last year, narrowly edging out rivals in a highly competitive legal advisory market.

Jan 30, 2026

Business

AI Bubble Fears Loom Over 2026 Markets, But This S&P 500 ETF Remains a Bedrock Strategy

As trillion-dollar AI infrastructure spending fuels concerns of a market bubble, long-term investors are questioning whether broad index funds like the Vanguard S&P 500 ETF still offer a safe harbor.

Jan 30, 2026

Business

C&S Wholesalers Deepens Southeast Roots with Key Sedano's Supermarket Supply Deal

The major wholesaler has been tapped as the primary supplier for Florida's prominent Hispanic grocery chain, Sedano's, marking the latest move in its aggressive expansion across the Southeastern U.S. retail landscape.

Feb 2, 2026

Business

PSEG Boosts Sustainability Credentials with High Recycling Rate, Adds Former PG&E CEO to Board

Public Service Enterprise Group (PEG) reports recycling more than 86% of its operational materials in 2024, as it strengthens its board with the appointment of former utility executive Geisha J. Williams, signaling a dual focus on environmental stewardship and governance.

Feb 2, 2026

Business

From $2.9 Billion to $7,386: How Tesla's Cybertruck Stumble Evaporated a Korean Family's Fortune

A South Korean family's paper wealth soared past $800 million after their company, L&F Co., inked a landmark battery materials deal with Tesla. Less than two years later, a quiet regulatory filing slashed the contract's value by 99.9997%, a collapse tied directly to Tesla's production struggles with its Cybertruck and 4680 battery cells.

Feb 2, 2026

Business

Siemens Healthineers Bets on Irish Innovation with New €10 Million R&D Hub

The medtech giant inaugurates a Centre of Excellence in Swords, aiming to accelerate development of its Atellica diagnostic systems and bolster Ireland's life sciences sector amid strategic corporate shifts.

Feb 2, 2026

Business

Banking Giants Line Up $7.9 Billion Debt Package to Fuel CD&R's Sealed Air Buyout

A syndicate led by JPMorgan and Wells Fargo is preparing a multi-billion dollar high-yield bond and loan issuance to finance the landmark private equity acquisition of Bubble Wrap maker Sealed Air, with bond yields expected to attract investor interest in the 7% range.

Feb 2, 2026

Business

Kinsale Capital Group's Stock Slump: A Buying Opportunity or a Warning Sign After Q3?

Shares of specialty insurer Kinsale Capital have tumbled over 11% in six months, starkly underperforming the surging S&P 500. As investors digest its latest earnings, the debate intensifies: Is this a rare chance to buy a high-growth company at a discount, or a signal of deeper challenges ahead?

Feb 2, 2026

Business

Factory Data Casts Shadow Over Markets: S&P 500 Futures Dip Amid Uneven Global Recovery Signals

U.S. stock futures retreated Monday as investors parsed a mixed bag of global manufacturing data, raising fresh questions about the durability of corporate earnings against a backdrop of cooling factory activity in key European economies.

Feb 2, 2026

Business

Crane Soars Past Q4 Estimates on Aerospace Strength, But Analysts Probe Integration Challenges

Crane Company's fourth-quarter earnings outperformed expectations, fueled by robust growth in its Aerospace & Advanced Technologies division. While management celebrated strong execution, analysts on the earnings call zeroed in on the costs and complexities of integrating recent high-profile acquisitions.

Feb 2, 2026

Business

Travere Therapeutics Under Investigation: Legal Scrutiny Clouds Biotech's Path to Profitability

Travere Therapeutics faces a securities fraud investigation by Robbins Geller Rudman & Dowd LLP, raising questions about the accuracy of its past disclosures. The probe casts a shadow over the company's critical transition, as it banks on its kidney drug FILSPARI to drive growth amid mounting legal and commercial pressures.

Feb 2, 2026

Business

M&A Market Roars Back to Life: 2026 Poised for Major Deal Surge as Confidence Returns

Fueled by a wave of blockbuster transactions and renewed executive optimism, the global mergers and acquisitions landscape is heating up for a robust 2026. Major consulting firms report a significant shift in sentiment, with U.S. CEOs leading the charge in pursuing strategic deals despite lingering market uncertainties.

Feb 2, 2026

Business

Johnson & Johnson Poised to Join $100 Billion Sales Club, Defying Industry Headwinds

The healthcare behemoth's robust 2025 results and 2026 guidance signal a landmark year ahead, as it navigates patent expirations and pricing pressures while maintaining its coveted dividend king status.

Jan 31, 2026